PMID: 9449260Feb 4, 1998Paper

Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases

Antimicrobial Agents and Chemotherapy
C PeñaF Gudiol

Abstract

An outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (ESBL-KP) was detected from May 1993 to June 1995. A total of 145 patients, particularly patients in intensive care units (ICUs) (107 patients [72%]), were colonized or infected. Infection developed in 92 (63%) patients, and primary bacteremia caused by ESBL-KP was the most frequent infection (40 of 92 patients [43%]). A single clone of ESBL-KP was identified by pulsed-field gel electrophoresis analysis throughout the whole period, and no molecular epidemiological relationship could be found between the epidemic strain and non-ESBL-KP isolates. To determine risk factors for ESBL-KP infection weekly rectal swabs were obtained in three serial incidence surveys (470 patients); the probabilities of carriage of ESBL-KP in the digestive tract were 33% (October and November 1993), 40% (May and June 1994), and 0% (October and November 1995) at 10 days of ICU admission. A logistic regression model identified prior carriage of ESBL-KP in the digestive tract (odds ratio, 3.4; 95% confidence interval 1.1 to 10.4) as an independent variable associated with ESBL-KP infection. A statistically significant correlation was observed between the restricted use of o...Continue Reading

References

Sep 1, 1979·Reviews of Infectious Diseases·J Z Montgomerie
Sep 1, 1991·Antimicrobial Agents and Chemotherapy·G A Jacoby, A A Medeiros
Nov 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G ArletA Philippon
Jun 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P LegrandA Philippon
Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Sep 1, 1971·The Journal of Hygiene·D van der Waaij Lekkerkerk Lekkerkerk-v
May 1, 1971·Annals of Internal Medicine·R SeldenT C Eickhoff
Nov 1, 1983·Reviews of Infectious Diseases·J E McGowan
Jul 1, 1983·Infection Control : IC·R P GaynesS A Kabins
Nov 1, 1984·Critical Care Medicine·J R Le GallD Villers
Sep 1, 1993·Annals of Internal Medicine·K S MeyerJ J Rahal
Jul 1, 1995·The Journal of Antimicrobial Chemotherapy·L C Hibbert-RogersC Bailey
Jul 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L B RiceD M Shlaes
Mar 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J C LucetB Regnier
Jun 1, 1996·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·W. Eugene Sanders, Christine C. Sanders

❮ Previous
Next ❯

Citations

Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A AsensioR Cantón
Feb 2, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J E McGowan
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A RebuckM E Rupp
Nov 23, 2001·Pharmacotherapy·S NathisuwanJ S Lewis
Aug 7, 2002·Critical Care Medicine·William J MossRodney E Willoughby
Jul 2, 2003·Drugs·Nelson LeeCyrus R Kumana
Nov 25, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Borut JutersekMarek Gniadkowski
Jan 28, 2005·The New England Journal of Medicine·George A Jacoby, Luisa Silvia Munoz-Price
Mar 26, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Craig MartinMartin Evans
Apr 6, 2006·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ianick Souto MartinsBeatriz Meurer Moreira
Nov 3, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L Galoisy-GuibalR Ecochard
May 24, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Emily P HyleEbbing Lautenbach
Oct 11, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Kerri A ThomAnthony D Harris
Jul 20, 2007·Journal of Clinical Pharmacy and Therapeutics·K UrbánekL Santavá
May 31, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·C LaurentB Byl
Oct 14, 2008·Expert Review of Anti-infective Therapy·Jesús Rodríguez-Baño, Alvaro Pascual
Jun 5, 2010·Scandinavian Journal of Gastroenterology·Abbas ChabokHåkan Hanberger
Jan 14, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·P Y BaşakA G Ozseven
Aug 24, 2012·Science Translational Medicine·Evan S SnitkinJulia A Segre
Aug 25, 2012·Interdisciplinary Perspectives on Infectious Diseases·Saoraya Lueangarun, Amorn Leelarasamee
May 25, 2013·BMJ Quality & Safety·Stig Ejdrup AndersenUNKNOWN Bispebjerg Intervention Group
Nov 30, 2018·The Pediatric Infectious Disease Journal·Lukas WisgrillAngelika Berger
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L Paterson, V L Yu
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J C LucetB Régnier
Oct 26, 2001·The Annals of Pharmacotherapy·B M Hodges, R L White
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D GuillemotUNKNOWN French Working Party to Promote Research to Control Bacterial Resistance
Jul 31, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Melek AyanZeynep Cizmeci
Jan 15, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Laura BriñasCarmen Torres
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·Deverick J AndersonKeith S Kaye
Sep 26, 2003·Current Opinion in Critical Care·Nina M ClarkJoseph P Lynch
Jun 19, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L PatersonVictor L Yu
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin J Llewelyn, Jonathan Cohen
Jun 19, 2008·Journal of Paediatrics and Child Health·Serap DemirAysegul Yagci
Mar 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R Ben-AmiY Carmeli
Oct 15, 2005·Clinical Microbiology Reviews·David L Paterson, Robert A Bonomo
Sep 14, 2007·Scandinavian Journal of Infectious Diseases·Axel KolaPetra Gastmeier

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.